ATE367151T1 - Kernformulierung - Google Patents

Kernformulierung

Info

Publication number
ATE367151T1
ATE367151T1 AT01930970T AT01930970T ATE367151T1 AT E367151 T1 ATE367151 T1 AT E367151T1 AT 01930970 T AT01930970 T AT 01930970T AT 01930970 T AT01930970 T AT 01930970T AT E367151 T1 ATE367151 T1 AT E367151T1
Authority
AT
Austria
Prior art keywords
core formulation
rosiglitazone
core
formulation
biguanide
Prior art date
Application number
AT01930970T
Other languages
English (en)
Inventor
Anthony Cutie
Akwete Adjei
Original Assignee
Aeropharm Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology Llc filed Critical Aeropharm Technology Llc
Application granted granted Critical
Publication of ATE367151T1 publication Critical patent/ATE367151T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
AT01930970T 2000-05-01 2001-05-01 Kernformulierung ATE367151T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20156700P 2000-05-01 2000-05-01
US70233200A 2000-10-31 2000-10-31

Publications (1)

Publication Number Publication Date
ATE367151T1 true ATE367151T1 (de) 2007-08-15

Family

ID=26896877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930970T ATE367151T1 (de) 2000-05-01 2001-05-01 Kernformulierung

Country Status (8)

Country Link
EP (1) EP1278513B1 (de)
JP (1) JP2004516234A (de)
AT (1) ATE367151T1 (de)
AU (2) AU2001257456B2 (de)
CA (1) CA2407713A1 (de)
DE (1) DE60129425T2 (de)
ES (1) ES2290130T3 (de)
WO (1) WO2001082867A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN192749B (de) * 2002-11-15 2004-05-15 Ranbaxy Lab Ltd
TW200517127A (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Novel composition
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
EP1841414A1 (de) * 2003-12-31 2007-10-10 Alpharma, Inc. Rosiglitazon- und metformin-formulierungen
EP1732513A2 (de) * 2003-12-31 2006-12-20 Alpharma, Inc. Formulierungen von rosiglitazon
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
AR076540A1 (es) * 2009-05-01 2011-06-22 Eurand Inc Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de analgesicos no- opioides y opioides, forma de dosificacion. metodo de preparacion. metodo para tratar dolor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
CA2069644A1 (en) * 1990-01-30 1991-07-31 Jan Feijen Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
CN1114404C (zh) * 1997-06-18 2003-07-16 史密丝克莱恩比彻姆有限公司 用噻唑烷二酮和二甲双胍治疗糖尿病
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
AU1403501A (en) * 1999-11-16 2001-05-30 Smithkline Beecham Plc Novel composition and use

Also Published As

Publication number Publication date
ES2290130T3 (es) 2008-02-16
WO2001082867A2 (en) 2001-11-08
DE60129425T2 (de) 2008-04-17
WO2001082867A3 (en) 2002-03-07
AU5745601A (en) 2001-11-12
EP1278513A4 (de) 2005-01-26
JP2004516234A (ja) 2004-06-03
EP1278513A2 (de) 2003-01-29
CA2407713A1 (en) 2001-11-08
EP1278513B1 (de) 2007-07-18
DE60129425D1 (de) 2007-08-30
AU2001257456B2 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
WO2001082875A3 (en) A core formulation
BR0214972B1 (pt) artigo absorvente.
BR0100865B1 (pt) artigo absorvente.
BR0103836B1 (pt) artigo absorvente.
BR0016218B1 (pt) artigo para fumar.
ITTO20010005A0 (it) Formulazione farmaceutica.
IT1319241B1 (it) Oggetto decorativo, in particolare di gioielleria.
BR0100151B1 (pt) artigo absorvente.
BR0210193B1 (pt) pelÍcula formada a vÁcuo e artigo absorvente.
DE60112656D1 (de) Beschichtungszusammensetzung, Beschichtungsverfahren und beschichteter Gegenstand
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
BR0211110B1 (pt) atadeira para jardinagem.
BR0212253B1 (pt) material e artigo para fumar.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
BR0102028B1 (pt) artigo absorvente.
DE60129425D1 (de) Kernformulierung
BR0100962B1 (pt) artigo absorvente.
ITTO20000385A0 (it) Composizione pesticida.
ITTO20000465A0 (it) Confezione per articoli igienico-sanitari e relativo procedimento di fabbricazione.
ITTO20000386A0 (it) Composizione pesticida.
BR0213766B1 (pt) artigo absorvente.
ATE254483T1 (de) Düse für die abgabe von wirkstoffen
MXPA03000975A (es) Composicion farmaceutica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1278513

Country of ref document: EP

REN Ceased due to non-payment of the annual fee